Filing Details
- Accession Number:
- 0000899243-20-012297
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-07 19:12:43
- Reporting Period:
- 2020-05-05
- Accepted Time:
- 2020-05-07 19:12:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1563577 | Galera Therapeutics Inc. | GRTX | Pharmaceutical Preparations (2834) | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1227367 | T Jon Holmlund | C/O Galera Therapeutics, Inc., 2 W Liberty Blvd #100 Malvern PA 19355 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-05-05 | 3,064 | $1.07 | 3,064 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-05-05 | 3,064 | $12.16 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-05-06 | 1,489 | $1.07 | 1,489 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-05-06 | 1,489 | $12.00 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-05-07 | 2,059 | $1.07 | 2,059 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-05-07 | 2,059 | $12.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2020-05-05 | 3,064 | $0.00 | 3,064 | $1.07 |
Common Stock | Stock Option | Disposition | 2020-05-06 | 1,489 | $0.00 | 1,489 | $1.07 |
Common Stock | Stock Option | Disposition | 2020-05-07 | 2,059 | $0.00 | 2,059 | $1.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
17,345 | 2023-01-22 | No | 4 | M | Direct | |
15,856 | 2023-01-22 | No | 4 | M | Direct | |
13,797 | 2023-01-22 | No | 4 | M | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019.
- The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $12.00 to $12.62. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $12.00 to $12.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option has fully vested and is currently exercisable.